University of Pittsburgh spacer UPMC spacer Health Sciences @ Pitt spacer School of Medicine spacer  
University of Pittsburgh Seal Univeristy of Pittsburgh
Department of Immunology
Academic Resources
About Us
Educational Programs
Giving & Development
Employment and Training Opportunities
Flow Facility
Immunology Grant Pre-Review Committee
Thomas E. Starzl Biomedical Science Tower
Phone: 412-383-9737
Fax: 412-383-8098
headshot Stephen H. Thorne , Ph.D.
Assistant Professor of Surgery
1A-106 HCC
5117 Centre Ave.
Pittsburgh, PA 15213
Phone: (412) 623-4896
Fax: (412) 623-2525
Faculty Research Interests
Research Interests
  • Designing and testing attenuated strains of vaccinia virus to act as oncolytic agents for the treatment of cancer
  • Testing of transgenes expressed from oncolytic vaccinia virus strains;
    especially effects of immunomodulatory genes and effects of controlling gene function
  • Effects of combining oncolytic viruses with immune cells as combination cancer therapies; especially the use of immune cells as carrier vehicles to deliver viruses to tumors
  • Use of Phosflow to examine host cell-pathogen interactions
  • Use of pre-clinical imaging (especially optical imaging) to non-invasively examine molecular events in vivo; especially in context of biological therapies for cancer and immune function
  • Ph.D. - Imperial College, London, UK (1998)
  • Postdoc - Surrey University, UK (1998-2000)
  • Postdoc - Cancer Research UK, London, UK (2000-2002)
  • Postdoc - Veteran's Affairs Hospital, Palo Alto, CA (2002-2003)
  • Postdoc - Stanford University, Stanford, CA (2003-2007)
    Academic Affiliation
  • Assistant Professor, Department of Surgery, University of Pittsburgh School of Medicine
  • Assistant Professor, Department of Immunology, University of Pittsburgh School of Medicine
    Selected Publications
  • Kirn DH, Wang Y, Le Boeuf F, Bell J, Thorne SH. Targeting of interferon-beta to produce a multi-mechanistic oncoloytic vaccinia virus. PLOS Med, in press. 2007.

  • Thorne SH, Hwang TH, O’Gorman BE, Bartlett DL, Sei S, Adiata F,
    Brown C, Werier J, Jo JH, Lee DE, Wang Y, Bell J, Kirn DH. Rational strain selection and engineering creates a broad spectrum systemically effective oncolytic poxvirus JX-963. J Clin Invest 117(11):3350-3358. 2007.

  • Thorne SH, Contag CH. Combining immune cell and viral therapy for the treatment of cancer. Cell Mol Life Sci 64(12): 1449-51. 2007.

  • Thorne SH. Strategies to achieve systemic delivery of therapeutic cells and microbes to tumors. Expert Opin Biol Ther 7(1): 41-51. 2007.

  • Au T, Thorne S, Korn M, Sze D, Kirn D, Reid T. Minimal hepatic
    toxicity of Onyx-015: Spatial restriction of coxsackie-adenoviral receptor in normal liver. Cancer Gene Ther 14(2):139-150. 2007.

    PubMed Link

    This website is maintained by the Health Sciences iTarget Team. If you have any technical difficulty please submit your help request here.
    © Office of the Senior Vice Chancellor for the Health Sciences, University of Pittsburgh. All rights reserved.
    Last Update